US Patent Issued to SHANGHAI HENLIUS BIOTECH on Sept. 15 for "Anti-GARP/TGF-Beta antibodies and methods of use" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,476, issued on Sept. 15, was assigned to SHANGHAI HENLIUS BIOTECH INC. (Shanghai).

"Anti-GARP/TGF-Beta antibodies and methods of use" was invented by Jiin-Tarng Wang (Shanghai), Chi-Ling Tseng (Shanghai), Wei-Dong Jiang (Shanghai), Bin Chen (Shanghai), Yao Xu (Shanghai) and Jie Gao (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are antibodies and antibody derivatives that bind to GARP (also known as LRRC32 and CPPRDD) and/or GARP/TGFBeta complex and methods of using the same. In certain embodiments, an anti-GARP/TGFBeta antibody or antibody derivative provided herein can inhibit a TGFBeta signal pathway in a target cell."

The pa...